UBS O'Connor’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-209,770
| Closed | -$722K | – | 444 |
|
|
2024
Q1 | $722K | Buy |
209,770
+29,347
| +16% | +$101K | 0.02% | 302 |
|
|
2023
Q4 | $444K | Sell |
180,423
-262,299
| -59% | -$645K | 0.01% | 353 |
|
|
2023
Q3 | $753K | Buy |
442,722
+40,000
| +10% | +$68K | 0.01% | 349 |
|
|
2023
Q2 | $1.21M | Buy |
402,722
+157,697
| +64% | +$473K | 0.03% | 362 |
|
|
2023
Q1 | $657K | Buy |
+245,025
| New | +$657K | 0.02% | 434 |
|
|
2022
Q4 | – | Sell |
-112,000
| Closed | -$862K | – | 49 |
|
|
2022
Q3 | $862K | Buy |
+112,000
| New | +$862K | 0.01% | 749 |
|